Tanzania - English - Tanzania Medicinces & Medical Devices Authority

africa biosystems tanzania ltd, tanzania - goat anti human polyclonal antibody -

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

africa biosystems limited, kenya - fetal hemoglobin antibody -

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

africa biosystems limited, kenya - cd71 monoclonal antibody -

Philippines - English - FDA (Food And Drug Administration)

lifeline diagnostics supplies, inc.; distributor: lifeline diagnostics supplies, inc. - id screen® influenza h5 antibody competition - diagnotics kit - n/a

United Kingdom - English - VMD (Veterinary Medicines Directorate)

ceva animal health ltd - chorionic gonadotrophin, serum gonadotrophin - powder and solvent for solution for injection - hormone sex - pigs

Australia - English - Department of Health (Therapeutic Goods Administration)

bio-rad laboratories pty ltd - 48446 - hiv1/hiv2 antigen/antibody ivd, kit, chemiluminescent immunoassay - the access hiv combo assay is intended to be used as an aid in the diagnosis of hiv-1 or hiv-2 infection and as screening test for blood and plasma donors. this assay is not intended for testing or screening pooled specimens. an access hiv combo assay result does not distinguish between the detection of hiv-1 p24 antigen, hiv-1 or hiv-1-o or hiv-2 antibodies.the access hiv combo assay is a sequential two-step immunoenzymatic (?sandwich?) assay the access hiv combo assay is a paramagnetic-particle, chemiluminescent immunoassay for the qualitative detection of hiv-1 p24 antigen and antibodies to hiv-1 (groups m and o) and hiv-2 in human serum and plasma (li heparin), using the access immunoassay systems.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd diagnostic division - 48446 - hiv1/hiv2 antigen/antibody ivd, kit, chemiluminescent immunoassay - for the qualitative detection of hiv p24 antigen and antibodies to human immunodeficiency virus type 1 and/or type 2 (hiv-1/hiv-2) in clinical specimens. the architect hiv ag/ab combo assay is a chemiluminescent microparticle immunoassay (cmia) for the simultaneous qualitative detection of hiv p24 antigen and antibodies to human immunodeficiency virus type 1 and/or type 2 (hiv-1/hiv-2) in human serum or plasma including specimens collected post-mortem (non-heart-beating) on the architect analyser. performance has been established for the use of cadaveric blood specimens (specimens collected post-mortem, non-heart beating) that have been collected up to 24 hours after death.

Australia - English - Department of Health (Therapeutic Goods Administration)

diasorin australia pty ltd - 48446 - hiv1/hiv2 antigen/antibody ivd, kit, chemiluminescent immunoassay - the liaison? xl murex hiv ab / ag assay uses chemiluminescence immunoassay (clia) technology for the combined qualitative determination of p24 antigen of human immunodeficiency virus type 1 (hiv-1) and specific antibodies to both human immunodeficiency virus type 1 (group m and group o) and/or human immunodeficiency virus type 2 (hiv-2) in human serum or plasma samples for the combined qualitative determination of p24 antigen of human immunodeficiency virus type 1 (hiv-1) and specific antibodies to both human immunodeficiency virus type 1 (group m and group o) and/or human immunodeficiency virus type 2 (hiv-2) in human serum or plasma samples. post mortem samples collected up to 24 hours after death have been tested and may be also used in the assay.

Australia - English - Department of Health (Therapeutic Goods Administration)

bio-rad laboratories pty ltd - 48449 - hiv1/hiv2 antigen/antibody ivd, control - the access hiv combo qc4 & qc5 is intended for monitoring system performance of the access hiv combo assay. the access hiv combo qc4 & qc5 is intended for monitoring system performance of the access hiv combo assay.

Australia - English - Department of Health (Therapeutic Goods Administration)

diasorin australia pty ltd - 48446 - hiv1/hiv2 antigen/antibody ivd, kit, chemiluminescent immunoassay - the liaison? xl murex hiv ab / ag ht assay uses chemiluminescence immunoassay (clia) technology for the combined qualitative determination of p24 antigen of human immunodeficiency virus type 1 (hiv-1) and specific antibodies to both human immunodeficiency virus type 1 (group m and group o) and/or human immunodeficiency virus type 2 (hiv-2) in human serum or plasma samples. ivds that are intended to be used in testing to provide information about infection with or exposure to human immunodeficiency viruses (hiv)